Latest Pharmaceutical Investments News

Page 1 of 1

LTR Pharma Boosts Stake in LevOmega to 43% with A$1m Investment

LTR Pharma has increased its ownership in LevOmega to approximately 43% through a strategic A$1 million investment, reinforcing its commitment to sustainable, pharmaceutical-grade omega-3 development.

Victor Sage

6 Oct 2025

Top